2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Mesothelioma Peritoneum: new trials by email Literature Review of Mesothelioma Peritoneum trials Research Report on Mesothelioma Peritoneum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO AMXT1501, DFMO - Cancer, Solid Tumor | Phase 1 / Phase 2 | Terminated | Aminex Therapeutics, Inc. | 15 | 2022-11-29 | 2024-12-24 |
| A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer TC-510, Fludarabine, Cyclophosphamide - Mesothelioma, Mesotheliomas Pleural | Phase 1 / Phase 2 | Terminated | TCR2 Therapeutics | 14 | 2022-06-21 | 2026-07-13 |
Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (2) · Mesothelioma, Malignant (2) · Ovarian Neoplasms (2) · Breast Neoplasms (1) · Cholangiocarcinoma (1) · Diffuse Intrinsic Pontine Glioma (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Glioma (1) · Head and Neck Neoplasms (1) · Melanoma (1) · Mesothelioma (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
Adenocarcinoma (2) · Adenoma (2) · Adnexal Diseases (2) · Breast Diseases (2) · Bronchial Neoplasms (2) · Carcinoma (2) · Carcinoma, Bronchogenic (2) · Colonic Diseases (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gastrointestinal Diseases (2)
Cyclophosphamide (1) · fludarabine (1)
Aminex Therapeutics, Inc. (1) · TCR2 Therapeutics (1)
United States (2) · Australia (1)
Michael Armstrong, MD (1) · Sue Lee, MD (1)